Core Insights - Company announced a projected revenue decline of approximately 15% for its drug delivery devices in the first half of 2025 compared to the previous year due to intensified market competition and product homogeneity [1] Company Strategy - The company is focusing on the blood purification sector as part of its strategic deployment [1] - Continuous product iteration and upgrades are planned, emphasizing safety, convenience, and precision in drug delivery devices [1] Market Trends - The aging population and increasing number of chronic disease patients are driving higher clinical demands for drug delivery devices in terms of safety, convenience, and precision [1] Product Development - The company is set to launch several new functional products, including precision filtration infusion, light-protective infusion, safe injection, and medical needle-free injection [1] - A new pre-filled catheter flushing device has been registered, extending the product line and providing safer and more efficient catheter care solutions for clinical treatment [1]
三鑫医疗:公司给药器具类产品包括输液、注射和留置导管等